Vanderbilt Health placed 19th in the Gartner Healthcare Supply Chain Top 25 for 2025, released by Gartner Inc., a technology research and consulting firm.
In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.
Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.
The 2025 QSRP Pursuit of Excellence Awards ceremony was combined with celebration of this year’s honorees of Vanderbilt’s Safety Superhero and Good Catch programs.
Risk of VTE rises in hospitals due to factors such as patient immobility, effects from major surgery, and use of indwelling medical devices like central lines.
Bestowed by the Infectious Diseases Society of America, the award “celebrates individuals who inspire and encourage others to make a difference.”